SCHEMBL5485829

SCHEMBL5485829

CCCCCCCCCCCCCCCCCCNC(=O)[CH]c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.73
NAAA Q02083 4/20 0.59
ZDHHC2 Q9UIJ5 2/20 0.59
ZDHHC20 Q5W0Z9 1/20 0.57
EPHX1 P07099 3/20 0.56
ALDH1A1 P00352 1/20 0.56
HTT P42858 1/20 0.56
KMT2A Q03164 1/20 0.53
HPGD P15428 1/20 0.51
HDAC3 O15379 2/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6726303 1.00 EGFR (0.73) EGFRNAAAZDHHC2ZDHHC20EPHX1
SCHEMBL5011517 0.98 EGFR (0.70) EGFRNAAAZDHHC2ZDHHC20EPHX1
SCHEMBL7220257 0.86 EGFR (0.54) EGFRZDHHC2ALDH1A1KMT2AHPGD
SCHEMBL28975079 0.84 EGFR (1.00) EGFRZDHHC2KMT2AHDAC3HDAC4
N-Hexadecylcinnamamide SCHEMBL2727701 0.84 EGFR (1.00) EGFRZDHHC2KMT2AHDAC3HDAC4
N-Octylcinnamamide SCHEMBL10706126 0.84 EGFR (1.00) EGFRZDHHC2KMT2AHDAC3HDAC4
N-Dodecylcinnamamide SCHEMBL28975087 0.84 EGFR (1.00) EGFRZDHHC2KMT2AHDAC3HDAC4
N-Dodecylcinnamamide SCHEMBL16596238 0.84 EGFR (1.00) EGFRZDHHC2KMT2AHDAC3HDAC4
N-Pentylcinnamamide SCHEMBL7913716 0.83 EGFR (0.97) EGFRZDHHC2KMT2AHDAC3HDAC4
N-Pentylcinnamamide SCHEMBL7913718 0.83 EGFR (0.97) EGFRZDHHC2KMT2AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223453-B2 Ink jet recording medium and ink jet recording method FUJIFILM CORPORATION (JP) 2007-05-29 US disclosed
EP-1525995-B1 Inkjet recording method FUJI PHOTO FILM CO LTD (JP) 2006-12-13 EP disclosed
US-7086726-B2 Inkjet recording method FUJI PHOTO FILM CO., LTD. (JP) 2006-08-08 US disclosed
EP-1525995-A1 Inkjet recording method FUJI PHOTO FILM CO., LTD. (JP) 2005-04-27 EP disclosed
US-20040166252-A1 Ink jet recording medium and ink jet recording method FUJI PHOTO FILM CO., LTD. 2004-08-26 US disclosed
EP-1426194-A2 Ink jet recording medium and ink jet recording method FUJI PHOTO FILM CO., LTD. (JP) 2004-06-09 EP disclosed
US-6720421-B2 STORAGE STABILITY: GOOD RAW-STOCK STORABILITY BEFORE RECORDING AND GOOD IMAGE STORABILITY AFTER RECORDING FUJI PHOTO FILM CO., LTD. (JP) 2004-04-13 US disclosed
US-20040012663-A1 Inkjet recording method FUJI PHOTO FILM CO., LTD. 2004-01-22 US disclosed
EP-1352754-A2 Inkjet recording method FUJI PHOTO FILM CO., LTD. (JP) 2003-10-15 EP disclosed
US-20030166961-A1 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative FUJI PHOTO FILM CO., LTD. 2003-09-04 US disclosed
US-20030064208-A1 Inkjet recording sheet FUJI PHOTO FILM CO., LTD. 2003-04-03 US disclosed
EP-1260379-A2 Inkjet recording sheet FUJI PHOTO FILM CO., LTD. (JP) 2002-11-27 EP disclosed
US-20020161225-A1 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative FUJI PHOTO FILM CO., LTD. 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166961-A1 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative UROD, ATIC, DDC EGFR 3714/4885NAAA 245/4885ZDHHC2 3728/4885
US-20020161225-A1 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative UROD, ATIC, DDC EGFR 3714/4885NAAA 245/4885ZDHHC2 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.